ANGELALIGN (06699) is accelerating its global business in the first half of 2026, with its market share in China steadily rising.

date
20:56 31/08/2026
avatar
GMT Eight
Angelalign (06699) announced that as of June 30, 2026, the total number of cases reached 316,609, representing a year-on-year growth of 40.2%.
On August 31, 2026, global invisible orthodontics company ANGELALIGN Technology Co., Ltd. (hereinafter referred to as ANGELALIGN or the Company) (06699) announced that as of June 30, 2026, the total number of cases reached 316,609, a year-on-year increase of 40.2%; the Companys revenue and net profit achieved year-on-year growths of 42.9% and 79.6%, respectively. In the first half of 2026, clinical practitioners increasingly prioritized clinically driven products and services, which propelled ANGELALIGNs business to realize rapid growth. Doctors hope to address complex orthodontic cases with invisible aligners, which necessitates effective clinical tools. ANGELALIGN optimizes related solutions around specific indications, simplifying and enhancing clinical workflows; the Company is also continuously building specialized systems to fully leverage the professional capabilities of doctors and help them achieve their clinical goals. At the same time, ANGELALIGN has fostered an open and collaborative corporate culture. The Company encourages outstanding talents to do the right thing and fully utilize their potential, with individuals from diverse cultural backgrounds and perspectives coming together around a shared passion for helping clients achieve clinical success; this corporate culture further promotes deep integration of global clinical experiences, allowing doctors from various countries and regions to share experiences, learn from one another, and contribute to the optimization of ANGELALIGN's products, software, and services. An increasing number of doctors worldwide are choosing ANGELALIGN's solutions, thanks to positive clinical outcomes, a rich product portfolio, and predictable treatment results. Dr. Mark Holt from Holt Orthodontics clinic in Northern California, USA, stated: Over half of our patients are treated with invisible aligner solutions, and ANGELALIGN's solutions have provided us with an outstanding user experience. During the reporting period, the global market (excluding Mainland China) performed particularly well, with the total number of invisible orthodontic cases reaching 168,001, a year-on-year increase of 43.4%, accounting for more than half of the Companys total cases, and achieving profitability; the market share in Mainland China steadily climbed, with the number of cases reaching 148,608, a year-on-year increase of 36.8%. ANGELALIGNs management is confident in the Companys ability to sustain growth and the enhanced momentum of its global business. ANGELALIGN's CEO Hu Jiezhang stated: Over the past few years, ANGELALIGN has continuously increased investment in product upgrades, professional education, direct sales networks, and local clinical service teams. These investments are gradually creating scale effects, making ANGELALIGN a trusted partner for orthodontists worldwide. We are deeply honored by the growing trust from our clients. Looking ahead, we believe the Company will continue to maintain its growth momentum and commit to increasing investments in innovation and client support. About ANGELALIGN Technology Co., Ltd. Founded in 2003, ANGELALIGN is dedicated to providing support to dental professionals and patients worldwide through digitally driven invisible orthodontic products and services. To date, the Company has serviced over 2 million cases, with a market value of $2 billion. With innovative products and technical services, the Company has become an important player in the orthodontics industry. ANGELALIGN was listed on the Hong Kong Stock Exchange in 2021, and since launching its globalization strategy in 2023, its products and services have expanded to more than 60 countries and regions worldwide. For more information, please visit angelalign.com. Forward-looking Statements This press release contains forward-looking statements. The relevant statements are based on the Company's current expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ significantly from the statements. Except as required by law, ANGELALIGN undertakes no obligation to update any forward-looking statements due to new information, future events, or other reasons.